Brochure
3 Oct 2026
Agriculture – Microbial Science for Better Crops
PDF 725 kB
Microbial science for better crops. Elmed's agricultural portfolio brings biological solutions for soil health, nutrient efficiency, plant growth and crop resilience. Bioshield (biofertilizer + biocontrol), Symbio (multi-functional N, P & K support), EL Guard (protection against soil-borne pathogens) and Green Biota (soil fertility and organic matter breakdown). Free-flowing, wettable formulations for seed treatment, soil application and all crops.
Content provided by our supplier
ELMED Life sciences Pvt Ltd
-
Country/Region:India
-
Founded:2018
-
On CPHI since:2025
-
Certificates:4
-
Employees:50 - 99
Company types
Primary activities
Other Content from ELMED Life sciences Pvt Ltd (4)
-
News ELMED Life Sciences to Exhibit at CPHI Milan 2026
ELMED Life Sciences, a Hyderabad-based probiotic contract manufacturer, will showcase its probiotic and microbiome solutions at CPHI Milan 2026, 6-8 October, Hall 16, Stand 16H75. Visit us to explore our latest formulations and contract manufacturing capabilities. -
Brochure MellowFlora – Women's Vaginal Health Probiotic
Balance begins within. MellowFlora is a premium women's vaginal health probiotic with 10 Billion CFU of HOWARU® strains: 5 Billion Lactobacillus rhamnosus and 5 Billion Lactobacillus acidophilus. Helps maintain healthy vaginal microbiota, supports healthy pH, bacterial and yeast balance for daily feminine wellness. Clinically studied with results seen in 7 days. 1-2 capsules daily. Available in 30 or 60 capsules. US FDA registered, GMP, HACCP and ISO certified.
-
Brochure Bacillus Clausii – Oral Suspension Portfolio
Elmed's clinically studied Bacillus clausii oral suspension portfolio for everyday gut wellness. Includes Endogermila® (2B CFU/5 mL), Endogermila® PLUS (4B CFU), Endogermila® Advanced with FOS + Zinc, and multi-strain Triogermila® (6B) and Triogermila® 10B. Supports gut microbiome balance, immunity and post-antibiotic recovery. Backed by a randomized, double-blind, placebo-controlled study showing shorter episodes and faster stool normalization.
